AI-Designed Antibiotics Combat Superbugs and Drug-Resistant Bacteria
TL;DR
AI has designed two new potential antibiotics targeting drug-resistant gonorrhoea and MRSA, showing promise in laboratory and animal tests, but they still require years of refinement and clinical trials before potential use in humans. The research highlights AI's role in revolutionizing antibiotic discovery amidst rising antibiotic resistance, though challenges remain in drug manufacturing and economic viability.
- AI designs new superbug-killing antibiotics for gonorrhoea and MRSA BBC
- Deep learning reveals antibiotics in the archaeal proteome Nature
- Superbugs Meet Their Match in Generative AI-Designed Drugs IEEE Spectrum
- Using generative AI, researchers design compounds that can kill drug-resistant bacteria MIT News
- Generative AI models build new antibiotics starting from a single atom Fierce Biotech
Want the full story? Read the original reporting
Read on BBC